Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2026 Feb 2;9(2):e2557620.
doi: 10.1001/jamanetworkopen.2025.57620.

Cerebral Oximetry-Guided Treatment and Cerebral Oxygenation in Extremely Preterm Infants: A Randomized Clinical Trial

Affiliations
Randomized Controlled Trial

Cerebral Oximetry-Guided Treatment and Cerebral Oxygenation in Extremely Preterm Infants: A Randomized Clinical Trial

Pranav R Jani et al. JAMA Netw Open. .

Abstract

Importance: Preterm infants are at high risk of developing brain injury, and near-infrared spectroscopy (NIRS) offers the ability to measure cerebral oxygenation. The impact of using a standardized treatment guideline combined with a single NIRS device manufacturer (Nonin Medical Inc) and neonatal sensor on cerebral oxygenation has not been previously examined.

Objective: To investigate whether cerebral oximetry with a dedicated treatment guideline improves cerebral oxygenation stability.

Design, setting, and participants: This was a single-blinded, 2-arm randomized clinical trial conducted from October 2021 to July 2024 at 5 tertiary neonatal intensive care units across Australia, New Zealand, and the US. Infants born at less than 29 weeks' gestation and aged younger than 6 hours underwent 1:1 random allocation stratified by gestational age (<26 weeks and ≥26 weeks) and study site.

Intervention: The intervention group received cerebral oximetry and dedicated guideline-based treatment when cerebral oxygenation was outside the range of 65% to 90%. The control group had blinded cerebral oximetry and treatment guided by standard clinical monitoring.

Main outcomes and measures: The burden of cerebral hypoxia and hyperoxia during the first 5 days after birth expressed as percentage hours was the primary outcome. Key secondary outcomes were mortality, morbidities before discharge, and NIRS-related skin injury.

Results: Of 149 screened infants (53 randomized to the intervention and 51 randomized to standard care), 100 infants were included in the final analysis (median [IQR] gestational age, 27 [25-28] weeks; 48 male [48.0%]). The median (IQR) birth weight was 883 (709-1079) g. The intervention group (50 infants) had a significantly lower median (IQR) burden of hypoxia and hyperoxia of 5.7% hours (2.8% hours to 15.0% hours) compared with 39.6% hours (6.5% hours to 82.3% hours) in the standard care group (50 infants), with an adjusted reduction of 42.8% hours (95% CI, 35.6% hours to 53.3% hours; P < .001). Mortality, morbidities before discharge, and safety outcomes were comparable between groups.

Conclusions and relevance: In this study, treatment guided by cerebral oximetry with a single device manufacturer and a neonatal sensor significantly improved the stability of cerebral oxygenation in extremely preterm infants. Larger multicenter trials are warranted to determine if this finding leads to improved survival without brain injury.

Trial registration: Australian New Zealand Clinical Trials Registry registration number ACTRN12621000778886.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Cruz reported receiving personal fees from the Australian National Health and Medical Research Council Clinical Trials Centre outside the submitted work. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Study Flowchart
Flow of study infants is presented as per the updated Consolidated Standards of Reporting Trials (CONSORT) reporting guideline. Other reasons were missed eligible participants and no research staff after hours for consenting. Recruitment by sites was as follows: 3 participants at site A, 32 participants at site B, 20 participants each at sites C and D, and 25 participants at site E.
Figure 2.
Figure 2.. Primary Outcome by Treatment
The burden of cerebral hypoxia and hyperoxia outside 65% to 90% is expressed as % hours based on the allocated group. Bold horizontal lines within boxes indicate medians; boxes, IQRs; lower whiskers, hinge to smallest value at most 1.5 × IQR of hinge; dots, individual values; upper whiskers, largest value no further than 1.5 × IQR from the hinge (edge of central box).

References

    1. Chow SSW, Creighton P, Hoberton JR, Chambers GM, Lui K.. Report of the Australian and New Zealand Neonatal Network. University of New South Wales; 2022. Accessed December 23, 2025. https://www.unsw.edu.au/content/dam/pdfs/medicine-health/npesu/research-...
    1. Henry G, Webb A, Galea C, et al. Out-of-pocket costs for families and people living with cerebral palsy in Australia. PLoS One. 2023;18(7):e0288865. doi: 10.1371/journal.pone.0288865 - DOI - PMC - PubMed
    1. Tonmukayakul U, Shih STF, Bourke-Taylor H, et al. Systematic review of the economic impact of cerebral palsy. Res Dev Disabil. 2018;80:93-101. doi: 10.1016/j.ridd.2018.06.012 - DOI - PubMed
    1. Achana F, Johnson S, Ni Y, et al. Economic costs and health utility values associated with extremely preterm birth: evidence from the EPICure2 cohort study. Paediatr Perinat Epidemiol. 2022;36(5):696-705. doi: 10.1111/ppe.12906 - DOI - PMC - PubMed
    1. Yates N, Gunn AJ, Bennet L, Dhillon SK, Davidson JO. Preventing brain injury in the preterm infant—current controversies and potential therapies. Int J Mol Sci. 2021;22(4):1671. doi: 10.3390/ijms22041671 - DOI - PMC - PubMed

Publication types

LinkOut - more resources